Impact of Blueberries on Uric Acid and Quality of Life
NCT01532622 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2013-10-22
Summary
The purpose of this study is to determine the impact of blueberries on uric acid in patients with hyperuricemia that are not receiving uric acid pharmacotherapy. The central hypothesis the investigators propose is that daily blueberries added to a pre-existing diet will promote uric acid lowering and improve quality of life without detriment to vital signs.
Conditions
- Hyperuricemia
Interventions
- DIETARY_SUPPLEMENT
-
Blueberry Powder
Patients will take 30 grams of blueberry powder daily for up to 30 days
- OTHER
-
Placebo Powder
Patients will take 30 grams of placebo powder daily for up to 30 days.
Sponsors & Collaborators
-
U.S. Highbush Blueberry Council
collaborator OTHER -
University of Mississippi Medical Center
lead OTHER
Principal Investigators
-
Daniel Riche, Pharm.D. · University of Mississippi Medical Center
-
Marion Wofford, M.D., M.P.H. · University of Mississippi Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 88 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-01-31
- Primary Completion
- 2013-10-31
- Completion
- 2013-10-31
Countries
- United States
Study Locations
More Related Trials
-
The Effect of Soursop Supplementation on Blood Pressure, Serum Uric Acid and Kidney Function in Prehypertensive Patients
NCT03531203 ·Status: COMPLETED ·Phase: NA
-
The Blood Pressure Effects of Febuxostat in Patients Previously Treated With Allopurinol: A Pilot Study
NCT01701622 ·Status: TERMINATED ·Phase: NA
-
The Diet Gout Trial
NCT03569020 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout
NCT00985127 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Increased Daily Water Intake in Patients With Hyperuricemia
NCT06315543 ·Status: COMPLETED ·Phase: NA
-
Effect of Febuxostat on Blood Pressure
NCT01496469 ·Status: COMPLETED ·Phase: PHASE2
-
Possible Pharmacological Effect of Quercetin in the Management of Hyperuricemia - Results From Real-life Clinical Studies
NCT06652035 ·Status: COMPLETED
-
Effect of Prebiotics on Hyperuricemia
NCT05385003 ·Status: UNKNOWN ·Phase: NA
-
Effect of the Consumption of a Combination of Plant Extracts (BSL_EP026) on Serum Uric Acid.
NCT04165499 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Tolerance, Pharmacokinetics / Pharmacodynamics (PK / PD) and Immunogenicity of Pegylated Uric Acid Oxidase for Injection in Healthy Adults and Hyperuricemia Volunteers
NCT05226013 ·Status: UNKNOWN ·Phase: PHASE1
-
Single Dose Study of SHR4640 in Healthy Subjects
NCT02815839 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacodynamics of SEL-037 (Pegsiticase) in Subjects With Elevated Blood Uric Acid Levels
NCT02464605 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of Intramuscular Uricase-PEG 20
NCT01038947 ·Status: UNKNOWN ·Phase: PHASE1
-
Food Effect Study of Febuxostat XR in Healthy Participants
NCT02374164 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of MBX-102 in Treatment of Hyperuricemia in Patients With Gout
NCT01336686 ·Status: COMPLETED ·Phase: PHASE2
-
D-0120 Safety and PK/PD, Food Effect Study in Healthy Volunteers
NCT03291782 ·Status: COMPLETED ·Phase: PHASE1
-
The Efficiency and Safety of Sodium Bicarbonate on Uric Acid in Patients With Asymptomatic Hyperuricemia or Gout
NCT03306758 ·Status: UNKNOWN ·Phase: NA
-
Vegan Diet, Amla Fruits and Uric Acid
NCT04801745 ·Status: COMPLETED ·Phase: NA
-
A Food-Drug Interaction Study of Serum Urate After Oral Inosine
NCT02614469 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Efficacy Trial of Burdock Root Extract in Patients With Asymptomatic Hyperuricaemia
NCT07002762 ·Status: RECRUITING ·Phase: NA
-
Nutraceutical on Hyperuricemia
NCT04161872 ·Status: COMPLETED ·Phase: PHASE4
-
Role of Uralyt-U in Patients With Hyperuricemia
NCT04352153 ·Status: UNKNOWN ·Phase: NA
-
Pegylated Recombinant Mammalian Uricase (PEG-uricase) as Treatment for Refractory Gout
NCT00111657 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of Intravenous Uricase-PEG 20
NCT01021241 ·Status: UNKNOWN ·Phase: PHASE1
-
Study of Febuxostat Effect on Blood Pressure in Patients With High Normal Blood Pressure
NCT01472692 ·Status: COMPLETED ·Phase: PHASE4